Prevalence of Self-Managed Abortion Among Women of Reproductive Age in the United States

被引:56
|
作者
Ralph, Lauren [1 ]
Foster, Diana G. [1 ]
Raifman, Sarah [1 ]
Biggs, M. Antonia [1 ]
Samari, Goleen [2 ]
Upadhyay, Ushma [1 ]
Gerdts, Caitlin [2 ,3 ]
Grossman, Daniel [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, Adv New Stand Reprod Hlth, San Francisco, CA USA
[2] Columbia Univ, Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY USA
[3] Ibis Reprod Hlth, Oakland, CA USA
关键词
FERTILITY RATES; HEALTH; RACISM;
D O I
10.1001/jamanetworkopen.2020.29245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This cross-sectional study examines the prevalence of and sociodemographic characteristics associated with reporting attempted self-managed abortion among US women. Importance Increasing evidence indicates that people are attempting their own abortions outside the formal health care system. However, population-based estimates of experience with self-managed abortion (SMA) are lacking. Objective To estimate the prevalence of SMA attempts among the general US population. Design, Setting, and Participants This cross-sectional survey study was fielded August 2 to 17, 2017 among English- and Spanish- speaking, self-identified female panel members from the GfK web-based KnowledgePanel. Women ages 18 to 49 years were approached to complete a 1-time survey. Data were analyzed from September 22, 2017, to March 26, 2020. Main Outcomes and Measures SMA was defined as "some women may do something on their own to try to end a pregnancy without medical assistance. For example, they may get information from the internet, a friend, or family member about pills, medicine, or herbs they can take on their own, or they may do something else to try to end the pregnancy." SMA was assessed using the question, "Have you ever taken or used something on your own, without medical assistance, to try to end an unwanted pregnancy?" Participants reporting SMA were asked about methods used, reasons, and outcomes. Factors associated with SMA experience, including age, race/ethnicity, socioeconomic status, nativity, reproductive health history, and geography, were assessed. Projected lifetime SMA prevalence was estimated using discrete-time event history models, adjusting for abortion underreporting. Results Among 14 151 participants invited to participate, 7022 women (49.6%) (mean [SE] age, 33.9 [9.0] years) agreed to participate. Among these, 57.4% (95% CI, 55.8%-59.0%) were non-Hispanic White, 20.2% (95% CI, 18.9%-21.5%) were Hispanic, and 13.3% (95% CI, 12.1%-14.5%) were non-Hispanic Black; and 15.1% (95% CI, 14.1%-16.3%) reported living at less than 100% federal poverty level (FPL). A total of 1.4% (95% CI, 1.0%-1.8%) of participants reported a history of attempting SMA while in the US. Projected lifetime prevalence of SMA adjusting for underreporting of abortion was 7.0% (95% CI, 5.5%-8.4%). In bivariable analyses, non-Hispanic Black (prevalence ratio [PR], 3.16; 95% CI, 1.48-6.75) and Hispanic women surveyed in English (PR, 3.74; 95% CI, 1.78-7.87) were more likely than non-Hispanic White women to have attempted SMA. Women living below 100% of the FPL were also more likely to have attempted SMA compared with those at 200% FPL or greater (PR, 3.43; 95% CI, 1.83-6.42). At most recent SMA attempt, 20.0% (95% CI, 10.9%-33.8%) of respondents used misoprostol, 29.2% (95% CI, 17.5%-44.5%) used another medication or drug, 38.4% (95% CI, 25.3%-53.4%) used herbs, and 19.8% (95% CI, 10.0%-35.5%) used physical methods. The most common reasons for SMA included that it seemed faster or easier (47.2% [95% CI, 33.0%-61.8%]) and the clinic was too expensive (25.2% [95% CI, 15.7%-37.7%]). Of all attempts, 27.8% (95% CI, 16.6%-42.7%) of respondents reported they were successful; the remainder reported they had subsequent facility-based abortions (33.6% [95% CI, 21.0%-49.0%]), continued the pregnancy (13.4% [95% CI, 7.4%-23.1%]), had a miscarriage (11.4% [95% CI, 4.2%-27.5%]), or were unsure (13.3% [95% CI, 6.8%-24.7%]). A total of 11.0% (95% CI, 5.5%-21.0%) of respondents reported a complication. Conclusions and Relevance This cross-sectional study found that approximately 7% of US women reported having attempted SMA in their lifetime, commonly with ineffective methods. These findings suggest that surveys of SMA experience among patients at abortion clinics may capture only one-third of SMA attempts. People's reasons for attempting SMA indicate that as abortion becomes more restricted, SMA may become more common. Question What is the prevalence of self-managed abortion (SMA) among US women of reproductive age? Findings In this cross-sectional survey of 7022 women aged 18 to 49, 1.4% reported ever having attempted SMA. Using age at SMA attempt and adjusting for underreporting of abortion, it is estimated that 7.0% of US women will attempt SMA at some point in their lives. Meaning These findings suggest that SMA is occurring in the US, highlighting the need for innovative models to ensure people have access to the safest and most effective methods of SMA, particularly where facility-based care is inaccessible.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] EXPERIENCES OF SELF-MANAGED ABORTION AMONG TRANSGENDER, NONBINARY, AND GENDER EXPANSIVE PEOPLE IN THE US
    Moseson, H.
    Fix, L.
    Ragosta, S.
    Hastings, J.
    Stoeffler, A.
    Lunn, M.
    Forsberg, H.
    Flentje, A.
    Lubensky, M.
    Obedin-Maliver, J.
    CONTRACEPTION, 2020, 102 (04) : 281 - 281
  • [42] Perspectives on self-managed abortion among providers in hospitals along the Texas–Mexico border
    Sarah Raifman
    Sarah E. Baum
    Kari White
    Kristine Hopkins
    Tony Ogburn
    Daniel Grossman
    BMC Women's Health, 21
  • [43] Demand for Self-Managed Online Telemedicine Abortion in the United States During the Coronavirus Disease 2019 (COVID-19) Pandemic
    Aiken, Abigail R. A.
    Starling, Jennifer E.
    Gomperts, Rebecca
    Tec, Mauricio
    Scott, James G.
    Aiken, Catherine E.
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (04): : 835 - 837
  • [44] Abortion providers' experiences and views on self-managed medication abortion: an exploratory study
    Kerestes, Courtney A.
    Stockdale, Colleen K.
    Zimmerman, M. Bridget
    Hardy-Fairbanks, Abbey J.
    CONTRACEPTION, 2019, 100 (02) : 160 - 164
  • [45] The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004
    Sutton, Madeline
    Sternberg, Maya
    Koumans, Emilia H.
    McQuillan, Geraldine
    Berman, Stuart
    Markowitz, Lauri
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (10) : 1319 - 1326
  • [46] Options for Teens with No Options: A Self-Managed Second Trimester Abortion
    Duroseau, Nathalie
    Loh, Miranda
    Sanders, Leslie
    Arden, Martha
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2021, 34 (02) : 226 - 227
  • [47] Self-managed abortion: Aligning law and policy with medical evidence
    Skuster, Patty
    Moseson, Heidi
    Perritt, Jamila
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2023, 160 (02) : 720 - 725
  • [48] Discovery of an Ectopic Pregnancy after Attempted Self-Managed Abortion
    Beshar, Isabel
    Liu, Serena M.
    Shaw, Kate A.
    Henkel, Andrea
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 278 - 279
  • [49] Ethical Care for Patients with Self-Managed Abortion After Roe
    Manns-James, Laura
    Pfeifer, Kelly
    Gillmor-Kahn, Mickey
    AMERICAN JOURNAL OF NURSING, 2023, 123 (01) : 38 - 44
  • [50] INTIMATE PARTNER VIOLENCE IS ASSOCIATED WITH SELF-MANAGED ABORTION IN BANGLADESH
    Crouthamel, B.
    Dixit, A.
    Pearson, E.
    Menzel, J.
    Paul, D.
    Shakhider, A. H.
    Silverman, J.
    Averbach, S.
    CONTRACEPTION, 2020, 102 (04) : 281 - 281